AVGO vs MANH Stock Comparison

MANH currently leads AVGO in this stock comparison, with AIQ scores of 71 vs 52. The clearest difference is momentum, while AVGO has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 19 points
AVGO
Technology
vs
MANH
Technology
AVGO
Broadcom Inc.
Price
$347
Day move
-4.76%
AIQ Score
52/100
Best edge
Value
Sector
Technology
MANH
Manhattan Associates, Inc.
Leads
Price
$257
Day move
+0.3%
AIQ Score
71/100
Best edge
Momentum
Sector
Technology

What is the main difference between AVGO and MANH?

MANH leads the current stock comparison as Manhattan Associates, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Broadcom Inc. vs Manhattan Associates, Inc.

Data as of Nov 15, 2026· market close· Technology· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

MANH leads

MANH leads by 19 AIQ points, primarily on Momentum and Risk Resilience, and the lead has widened from 14 points over 30 sessions. Wall Street currently favors AVGO on target upside.

Competitive: 3 of 6 evidence groups support MANH, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Strengthening
AVGO

Broadcom Inc.

AIQ Score
52/100
AIQ Edge Score
7/10
MANH

Manhattan Associates, Inc.

Leads
AIQ Score
71/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors MANH over AVGO, 71 versus 52 as of Nov 15, 2026. MANH's advantage is driven primarily by stronger momentum and risk resilience, while AVGO holds the stronger value profile. MANH also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AVGO. 3 of 6 covered evidence groups favor MANH today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. MANH lead: Strengthening — the AIQ differential moved from 14 to 19 points over 30 sessions.

Compare Broadcom Inc. and Manhattan Associates, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AVGO
+565.5%
MANH
+51.8%

Total return comparison

Growth of $10,000, distributions reinvested

AVGO $66,548 · MANH $15,176

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AVGO and MANH against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AVGO advantage
0
MANH advantage
  • Momentum40 vs 94
    MANH +54
  • Risk Resilience47 vs 69
    MANH +22
  • Value50 vs 39
    AVGO +11
  • Quality69 vs 66
    Even

3 of 6 evidence groups favor MANH. MANH’s edge is concentrated in momentum and risk resilience; AVGO keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

AVGO0 AIQ

Largest factor move: Momentum -2, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 6 active signals are unchanged.

MANH0 AIQ

No factor moved materially.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-11.2%)
  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

MANH's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — AVGO and MANH both carry a full feed there.

The central trade-off

MANH (Manhattan Associates, Inc.): the stronger current systematic profile, led by momentum and risk resilience.

AVGO (Broadcom Inc.): the counter-case, on value, fundamentals, valuation — but at materially higher volatility, 70% against 26.1%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

MANH

MANH on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AVGO

AVGO on combined revenue and EPS growth.

Value

AVGO

AVGO on the peer-relative Value factor, by 11 points.

Momentum

MANH

MANH on the Momentum factor, by 54 points.

Lower downside

MANH

MANH on Risk Resilience, by 22 points.

Analyst upside

AVGO

AVGO on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors MANH, analyst targets favor AVGO. That disagreement is the most useful thing on this page.

MeasureAVGOMANHNote
Implied upside to target+48.5%+8.5%AVGO has more room
Target dispersion+48.5%+19.7%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering5111Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor MANH. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreMANH52 vs 71
FundamentalsAVGOon balancerevenue growth 33.4% vs 2.8%; EPS growth 40.3% vs 23.5%; TTM ROE 13.1% vs 30.6%; gross margin 68.8% vs 54.9%; operating margin 48.4% vs 24.1% — AVGO takes 4 of 5 decided legs, not all of them
ValuationAVGOValue 50 vs 39
TechnicalsMANHPrice vs 50-day 0.5% vs 14.7%; vs 200-day -5.6% vs 50.6%
Risk ResilienceMANHRisk Resilience 47 vs 69
Analyst expectationsAVGOTarget upside 48.5% vs 8.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and MANH and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 19 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on MANH.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

MANH lead: Strengthening — the AIQ differential moved from 14 to 19 points over 30 sessions.

May 27AVGO leads above the line · MANH leads belowNov 13
Today
MANH +19
52 vs 71
7 sessions ago
MANH +21
50 vs 71
30 sessions ago
MANH +14
55 vs 69
90 sessions ago
MANH +6
59 vs 65

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AVGOConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only AVGO

  • Death Cross Active — bearish, trend, long horizon (6.38%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.14%)
  • Accumulation Pattern — bullish, volume, medium horizon (1.18x)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
MANHConflicted

5 bullish / 3 bearish, conflicted

Only MANH

  • Golden Cross Active — bullish, trend, long horizon (31.29%)
  • 52-Week High Proximity — bullish, risk_regime, long horizon (1.9%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-11.2%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.35x)
  • MACD Bearish Crossover — bearish, momentum, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

MANH leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AVGONo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -4.76%, AIQ 0 points).

MANHNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.3%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1AVGO closes the Momentum gap — currently 54 points behind, the largest single contributor to MANH's edge.
  2. 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3MANH's conflicting signal state resolves bearish — it currently carries 5 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AVGO leads on balance
MetricAVGOMANH
Revenue growth (YoY)33.4%2.8%
EPS growth (YoY)40.3%23.5%
Gross margin68.8%54.9%
Operating margin48.4%24.1%
Return on equity (TTM)13.1%30.6%
Debt to equity0.60.26

Performance

MANH leads 5 of 6 windows
MetricAVGOMANH
1 week (5 sessions)18.2%1.7%
1 month (20 sessions)5.6%15.7%
3 months (63 sessions)-11.6%30.9%
6 months (126 sessions)-18.4%95.8%
Year to date0.3%48.4%
1 year (252 sessions)-2.3%46.7%

Technicals

MANH has the stronger structure
MetricAVGOMANH
RSI (14)53.267.7
ADX (14)2338.8
Price vs 50-day0.5%14.7%
Price vs 200-day-5.6%50.6%
Volatility (1M, annualized)70%26.1%

Risk

MANH is the more resilient
MetricAVGOMANH
Beta2.210.24
Sharpe ratio0.210.94
Sortino ratio0.291.47
Max drawdown-39.5%-32.7%
Current drawdown-27.9%-1.3%
Annualized volatility48.6%46.9%
Value at risk (95%)-4.6%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AVGO or MANH?

On the Algovestiq AIQ Score, MANH is the stronger of the two as of Nov 15, 2026, scoring 71 against AVGO's 52. The edge comes from momentum and risk resilience. AVGO is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AVGO or MANH the better buy right now?

MANH carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor MANH over AVGO?

The composite weights Quality, Value, Momentum and Risk Resilience. MANH leads Momentum by 54 points; MANH leads Risk Resilience by 22 points; AVGO leads Value by 11 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AVGO or MANH?

Analyst price targets imply +48.5% upside for AVGO and +8.5% for MANH, so the Street currently favors AVGO. That points the opposite way to the AIQ Score, which favors MANH. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AVGO or MANH?

AVGO is the better-valued of the two on the peer-relative Value factor. AVGO on the peer-relative Value factor, by 11 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AVGO or MANH?

AVGO on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AVGO or MANH?

MANH on the Momentum factor, by 54 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AVGO or MANH?

MANH is the more resilient of the two, so the other name carries the higher downside risk. MANH on Risk Resilience, by 22 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AVGO more profitable than MANH?

The profitability evidence is mixed: gross margin 68.8% vs 54.9%; operating margin 48.4% vs 24.1%; ttm roe 13.1% vs 30.6%. AVGO leads on two measures and MANH on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is MANH's lead over AVGO getting stronger or weaker?

MANH lead: Strengthening — the AIQ differential moved from 14 to 19 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the AVGO vs MANH verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Momentum gap — currently 54 points behind, the largest single contributor to MANH's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; MANH's conflicting signal state resolves bearish — it currently carries 5 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about AVGO and MANH?

AVGO: 2 bullish / 2 bearish / 2 neutral, conflicted. MANH: 5 bullish / 3 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon). On MANH it is Golden Cross Active (bullish, long horizon).

Compare AVGO and MANH with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.